MNTA: OK, but 1. Fragmin is wholly-owned by MNTA. 2. The 2 undisclosed protein FoB's garner such a huge potential market that any royalty arrangement should be quite substantial for MNTA. Evidence the slide below regarding the M356 Copaxone arrangement:
"Illegitimacy is something we should talk about in terms of not having it."